GENB (Generate Biomedicines) Beneish M-Score


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines Beneish M-Score?

Generate Biomedicines does not have enough data to calculate Beneish M-Score.

Generate Biomedicines Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines Beneish M-Score Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
Beneish M-Score
0.00 0.00

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
Beneish M-Score 0.00 0.00

GENB vs PVLA, SLBT, NKTR: Beneish M-Score Comparison

For the Biotechnology subindustry, Generate Biomedicines's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Generate Biomedicines Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Generate Biomedicines's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Generate Biomedicines's Beneish M-Score falls into.


GENB
6GF Score
Generate Biomedicines Inc GENB
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price